Rh growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +4.8%
EBITDA: +12.0%
EBIT: +2.9%
EPS: +20.9%
Free cash flow: +236.7%
Operating cash flow: +638.8%

Forward estimates

Revenue: +12.1%
EBITDA: +52.1%
EPS: +107.1%

Three-year CAGR

Revenue: -1.4%
EBITDA: -11.3%
EBIT: -19.6%
Net income: -38.2%
EPS: -33.4%
Free cash flow: +3.1%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.